Bayer to withdraw follicular lymphoma therapy after trial failure

Bayer to withdraw follicular lymphoma therapy after trial failure

Source: 
Clinical Trials Arena
snippet: 

German multinational pharmaceutical company Bayer has announced plans to voluntarily withdraw its new drug application in the US for Aliqopa (copanlisib) to treat relapsed follicular lymphoma (FL) following a failed trial.